Under the hood of drug-price controlNigel Rawson and John Adams | Financial Post | July 24, 2020Post navigationPrevious Government refuses to address real cause of missing cystic fibrosis treatment in CanadaNext Exempting COVID medicines from new price controls: Ottawa hypocrisy